ERJ Open ResearchGenetic & Genomic MedicinePeer-reviewed journal article
Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis
Beatriz Guillén‐GuíoiD, Megan L. PayntoniD, Richard J. AlleniD, D ChiniD, Lauren J. DonoghueiD, Amy Stockwell, Olivia C. LeavyiD, Tamara Hernández-BeeftinkiD, Carl ReynoldsiD, Paul CullinaniD, Fernando J. MartíneziD, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, Helen Booth, William A. FahyiD, Ian P. HalliD, Simon Paul HartiD, Mike R. Hill, Nik HiraniiD, Richard B Hubbard, Robin J. McAnultyiD, Ann Millar, Vidya V. NavaratnamiD, Eunice Oballa, Helen ParfreyiD, Gauri SainiiD, , Edward J. HolloxiD
Abstract
IntroductionIdiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the pathogenesis of IPF and a prior association of the HLA-DQB1 gene with idiopathic fibrotic interstitial pneumonia (including IPF) has been reported. Due to the important role that the Human Leukocyte Antigen (HLA) region plays in the immune response, here we evaluated if HLA genetic variation was associated specifically with IPF risk. MethodsWe performed a meta-analysis of associations of the HLA region with IPF risk in individuals of European ancestry from seven independent case-control studies of IPF (comprising a total of 5,159 cases and 27,459 controls, including the prior study of fibrotic interstitial pneumonia). Single nucleotide polymorphisms, classical HLA alleles and amino acids were analysed and signals meeting a region-wide association threshold p90% were considered significant. We sought to replicate the previously reported HLA-DQB1 association in the subset of studies independent of the original report. ResultsThe meta-analysis of all seven studies identified four significant independent single nucleotide polymorphisms associated with IPF risk. However, none met the posterior probability for replication criterion. The HLA-DQB1 association was not replicated in the independent IPF studies. ConclusionVariation in the HLA region was not consistently associated with risk in studies of IPF. However, this does not preclude the possibility that other genomic regions linked to the immune response may be involved in the aetiology of IPF.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 7
- FWCI
- 1.29
- Field percentile
- top 19%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic landscape of idiopathic pulmonary fibrosis: A systematic review, meta-analysis and epidemiological evidence of case-control studies
Pooja Singh, Debleena Guin, … Ritushree Kukreti·medRxiv·May 18, 2023
- Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants
Ritah Nabunje, Beatriz Guillén‐Guío, … Richard J. Allen·medRxiv·Apr 25, 2026
- Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis
Richard J. Allen, Beatriz Guillén‐Guío, … Louise V. Wain·American Journal of Respiratory and Critical Care MedicinePeer-reviewed·Nov 11, 2019
- Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis
Richard J. Allen, Amy Stockwell, … Louise V. Wain·ThoraxPeer-reviewed·Jun 10, 2022
- Integrative Analyses Reveal Novel Disease-associated Loci and Genes for Idiopathic Pulmonary Fibrosis
Ming Chen, Yiliang Zhang, … Hongyu Zhao·ThoraxPeer-reviewed·Oct 10, 2022
- Leveraging global multi-ancestry meta-analysis in the study of Idiopathic Pulmonary Fibrosis genetics
Juulia Partanen, Paavo Häppölä, … Jukka T. Koskela·Cell GenomicsPeer-reviewed·Oct 1, 2022